Interestingly another study, which reported increased levels of LPS and sCD14 along with some other biomarkers not included in this analysis (such as LBP, I-FABP, MCP-1 and C-reactive protein) was able to correctly discriminate between ME/CFS and controls with a cross-validation accuracy of 82.9% (14). This evidence concerns the gene CRP and myalgic encephalomeyelitis/chronic fatigue syndrome.